Medication info

Amlodipine Rosuvastatin 5/50 mg Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
White, rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201903027 · Approved 2019.05.10

This product's status changed to Expired on 2024.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension when monotherapy provides inadequate control or initial combination therapy is needed
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 50 milligrams. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 100 milligrams. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients receiving dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension when monotherapy provides inadequate control or initial combination therapy is needed

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension who find it difficult to control their blood pressure with Amlodipine or Losartan monotherapy. It is also used as initial treatment for patients with Stage 2 hypertension who require combination therapy to reach their target blood pressure. Therefore, this medication is effectively used for hypertension treatment.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 50 milligrams. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or losartan 100 milligrams. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients receiving dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm or death to the fetus if taken during pregnancy, especially in the second and third trimester, so it should be discontinued immediately upon confirmation of pregnancy. Additionally, hypotension may occur when initially administered to patients with reduced effective blood volume, thus such conditions should be treated before use. It should not be used in patients with hypersensitivity to this medication, severe liver impairment, severe aortic stenosis, or in a state of shock. Due to the blood pressure-lowering effect, dizziness may occur; thus caution is required when driving or operating hazardous machinery. This medication should be administered carefully in elderly patients or those with impaired kidney function, as there is a risk of hyperkalemia, hence potassium level monitoring is necessary. Care should be taken with combined use of other antihypertensives as the effect may be enhanced. Pregnant and breastfeeding women are advised not to take this medication, particularly during pregnancy, as it poses serious risks to the fetus and newborn. Safety in children has not been established, and therefore it is not recommended. In case of overdose, severe hypotension and cardiac dysfunction may occur; immediate medical attention is required if symptoms arise. This medication should be stored out of reach of children and not transferred to other containers.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial malformations
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 200 more
  • patent ductus arteriosus
  • symptoms of hypotension
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory impairment
  • paraesthesias
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremors
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • lumbago
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • erythematous rash
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • lumbago
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • panic disorder
  • sleep disorders
  • tremors
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning eyes
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • liver dysfunction
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • hypotension
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1°C and 30°C at room temperature. Proper storage will help maintain its effectiveness for a prolonged period.

Appearance and packaging

Appearance

White, rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.